Valuation: Uscom Limited

Market Cap 3.12M 2.17M 1.93M 1.8M 1.64M 3.09M 209M 21.79M 8.46M 107M 8.15M 7.97M 342M P/E 2024
-1.25x
P/E 2025 -0.88x
Enterprise Value 4.42M 3.07M 2.73M 2.54M 2.32M 4.38M 296M 30.84M 11.97M 151M 11.54M 11.29M 485M EV / Sales 2024
0.57x
EV / Sales 2025 2.06x
Free-Float
17.04%
Yield 2024 *
-
Yield 2025 -
3 years 0.01
Extreme 0.011
0.05
5 years 0.01
Extreme 0.011
0.14
10 years 0.01
Extreme 0.011
0.53
Manager TitleAgeSince
Chief Executive Officer - 07/03/2011
Corporate Secretary 66 24/05/2016
Corporate Officer/Principal - 28/05/2018
Director TitleAgeSince
Chairman - 01/11/2009
Director/Board Member 66 23/08/2018
Director/Board Member 62 16/12/2019
Change 5-day change 1-year change 3-year change Capi.($)
+9.09%-.--%-.--%-76.00% 2.17M
+0.35%-2.99%+20.52%+31.06% 242B
+1.09%-4.65%-0.43%-0.76% 150B
-2.32%-3.27%-13.35%+36.07% 138B
-1.46%-3.01%-56.23%-17.35% 61.74B
-0.05%-1.32%+10.48%+22.34% 49.08B
+0.66%+0.19%-20.53%-20.70% 47.43B
+0.66%-2.90%+18.46%+52.17% 47.3B
-3.05%-2.62%-7.75%+36.49% 44.25B
-0.08%-1.92%+29.48%+60.45% 41.78B
Average +0.49%-2.25%-1.93%+12.38% 82.26B
Weighted average by Cap. -0.29%-3.27%+1.08%+21.95%

Financials

2024 2025
Net sales 3.73M 2.59M 2.3M 2.15M 1.96M 3.69M 250M 26.01M 10.1M 127M 9.73M 9.52M 409M 2.58M 1.79M 1.59M 1.49M 1.35M 2.56M 173M 18M 6.99M 88.15M 6.73M 6.59M 283M
Net income -2.07M -1.44M -1.28M -1.19M -1.09M -2.06M -139M -14.48M -5.62M -70.92M -5.42M -5.3M -228M -3.3M -2.3M -2.04M -1.9M -1.73M -3.27M -221M -23.05M -8.95M -113M -8.62M -8.43M -362M
Net Debt -1.53M -1.06M -945K -882K -803K -1.52M -102M -10.68M -4.15M -52.32M -4M -3.91M -168M 1.3M 902K 801K 747K 680K 1.29M 86.85M 9.05M 3.51M 44.34M 3.39M 3.31M 142M
Logo Uscom Limited
Uscom Limited is an Australia-based medical technology company specializing in development and marketing of non-invasive cardiovascular and pulmonary medical devices. The Company offers three suites of devices in the field of cardiac, vascular and pulmonary monitoring: the USCOM 1A advanced haemodynamic monitor, the Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic digital ultrasonic spirometers. The USCOM 1A is a non-invasive advanced haemodynamic monitor that measures cardiovascular function, detects irregularities and is used to guide treatment. The Uscom BP+ is a supra-systolic oscillometric central blood pressure monitor which measures blood pressure and blood pressure waveforms at the heart, as well as in the arm, information only previously available using invasive cardiac catheterization. The Uscom SpiroSonic digital ultrasonic spirometers are high fidelity, digital, pulmonary function testing devices based on multi-path ultrasound technology.
Employees
35